Genital transmission of human papillomavirus in recently formed heterosexual couples

Journal of Infectious Diseases

Volumn 204, Issue 11, 2011, Pages 1723-1729

  Burchell, Ann N ^a   Coutlée, Franois ^a,c   Tellier, Pierre Paul ^a   Hanley, James ^b   Franco, Eduardo L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Epidemiology Biostatistics and Occupational Health ^*  (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CANADA; CARCINOGENICITY; FEMALE; FOLLOW UP; GENOTYPE; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 66; INFECTION SENSITIVITY; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; VIRUS TRANSMISSION; WART VIRUS;

ADULT; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; GENOTYPE; HETEROSEXUALITY; HUMANS; LONGITUDINAL STUDIES; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUEBEC; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES, VIRAL; YOUNG ADULT;

EID: 80155207262     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir644     Document Type: Article

References (25)

1. International Agency for Research on Cancer (IARC) Working Group. Human papillomaviruses. In: IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 64. Lyon, France: International Agency for Research on Cancer, 1995.
2. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030-44.
3. Oriel JD. Natural history of genital warts. Br J Vener Dis 1971; 47:1-13.
4. Bogaards JA, Xiridou M, Coupe VM,Meijer CJ,Wallinga J, Berkhof J. Model-based estimation of viral transmissibility and infectioninduced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. Am J Epidemiol 2010; 171:817-25.
5. Burchell A, Richardson H, Mahmud S, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163:534-43.
6. Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Human papillomavirus infections among couples in new sexual relationships. Epidemiology 2010; 21:31-7.
7. Hernandez B, Wilkens L, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14:888-94.
8. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189:677-85.
9. Wright T Jr., Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-6.
10. Sellors J, Lorincz A, Mahony J, et al. Comparison of self-collected vaginal, vulvar, and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Can Med Assoc J 2000; 163:513-8.
11. Gravitt P, Lacy J, Brinton L, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Rev 2001; 10:95-100.
12. Coutlée F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 2006; 44:1998-2006.
13. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens. Part B. Biological agents. Lancet Oncol 2009; 10:321-2.
14. Widdice L, Ma Y, Farhat S, Jonte J, Breland D, Moscicki AB. Concordance and transmission of human papillomavirus. Poster P-612 presented at: 26th International Papillomavirus Conference; 2010; Montreal, Canada. http://hpv2010.org. Accessed 28 September 2011.
15. Mbulawa ZZA, Marais DJ, Coetzee D, Williamson AL. HPV transmission in heterosexually active couples over 12 months. Paper presented at: 26th International Papillomavirus Conference; 2010; Montreal, Canada. Presentation 316. http://hpv2010.org. Accessed 28 September 2011.
16. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011; 377:932-40.
17. Villa L, Perez G, Kjaer S, et al. Quadrivalent vaccine against human papillomaviruses to prevent high-grade cervical lesions. New Engl J Med 2007; 356:1915-27.
18. Paavonen J, Jenkins D, Bosch F. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369:2161-70.
19. Castle PE. The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer 2009; 4:7:doi:10.1186/1750-9378-4-7.
20. Trottier H, Franco E. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(Suppl 1):S4-S15.
21. Trottier H, Ferreira S, Thomann P, et al. HPV infection and re-infection in adult women: The role of sexual activity and natural immunity. Cancer Res 2010; 70:8569-77.
22. BleekerMC, Snijders PF, Voorhorst FJ,Meijer CJ. Flat penile lesions: The infectious ''invisible'' link in the transmission of human papillomavirus. Int J Cancer 2006; 119:2505-12.
23. Schlecht N, Trevisan A, Duarte-Franco E, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003; 103:519-24.
24. Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Prétet J. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol 2006; 35:270-7.
25. Bleeker M, Hogewoning C, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41:612-20.